Linz, Austria

Rudolf Franzmair

This inventor holds 11 USPTO granted patents. Top assignees: Chemie Linz Aktiengesellschaft, Clarion Pharmaceuticals Inc., Boehringer Ingelheim Gmbh. Active years: 1976-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rudolf Franzmair. Retrieved from https://idiyas.com/inventor/rudolf-franzmair

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 1.6

ph-index = 4

Forward Citations = 50(Granted Patents)


Location History:

  • Linz-Ebelsberg, OE (1976)
  • Linz-Ebelsberg, AT (1979)
  • Linz, AT (1979 - 1999)

Company Filing History:


Years Active: 1976-1999

Loading Chart...
11 patents (USPTO):Explore Patents

Title: **Rudolf Franzmair: A Pioneer in Pharmaceutical Innovations**

Introduction

Rudolf Franzmair, an esteemed inventor based in Linz, Austria, has made significant contributions to the field of pharmaceuticals, holding a remarkable total of nine patents. His innovative research focuses primarily on the development of new compounds that exhibit promising antibacterial and antiviral properties. Franzmair’s work has been influential in the pursuit of effective treatments for various health conditions.

Latest Patents

Among his latest patents are the “Heteroaryl-substituted deoxy glycerols” and “Heteroaryl-substituted deoxy glycero-phosphoethanolamines.” These compounds are known for their potential benefits in treating diseases. The first patent discloses compounds represented by specific general formulas, featuring variations of oxygen or sulfur, and showcasing a variety of alkyl or alkenyl configurations. These compounds have been shown to possess significant antiviral and antibacterial activities.

The second patent details therapeutically active heteroaryl-substituted deoxy glycero-phosphoethanolamines, which consists of unique substituents that allow for targeted treatment of conditions such as cancerous tumors, psoriasis, and inflammation. The innovative nature of these compounds marks a significant advancement in pharmaceutical development.

Career Highlights

Franzmair’s career includes invaluable experiences at notable organizations like Chemie Linz Aktiengesellschaft and Clarion Pharmaceuticals Inc. His dedication to advancing pharmaceutical research has positioned him as a reputable inventor in the industry. His contributions are widely recognized and appreciated, particularly for their impact on health and medicine.

Collaborations

Throughout his career, Rudolf has collaborated with esteemed colleagues such as Friedrich Paltauf and Albin Hermetter. These partnerships have fostered an environment of innovation, enabling the development of groundbreaking pharmaceutical solutions and enhancing the efficacy of his research.

Conclusion

In summary, Rudolf Franzmair's innovative contributions to the pharmaceutical industry through his patents reflect his commitment to addressing critical health challenges. His focus on developing compounds with antiviral and antibacterial properties continues to pave the way for advancements in therapeutic treatments, showcasing the importance of inventions in improving human health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…